Meda AB (publ) AGM bulletin

At the annual general meeting (AGM) on April 14, 2016, of Meda AB (publ), an unchanged dividend of 2.50 SEK per share was declared.

The AGM adopted balance sheets and income statements and discharged the members of the board and the CEO from liability.

Further, the AGM resolved to adopt the nomination committee’s proposal for remuneration to the board and the auditors. The board was elected according to the nomination committee´s proposal. The AGM also resolved to elect auditor in accordance with the nomination committee’s proposal.

The AGM also authorized the board to make decisions on the issue of shares, and on buying and selling Meda shares.

Details of the AGM resolutions are available at Meda’s head office at Pipers väg 2A, Solna Sweden, or by calling +46 8 630 1900. They will be sent on request free of charge to shareholders who provide an address.

For further inquiries, please contact:

Paula Treutiger, VP Corporate Communications & Sustainability                                     ph: +46 733-666 599                                                                                                                                                                                                        

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.


Documents & Links